SecBot SecBot

HRZN

Horizon Technology Finance Corp
Nasdaq· CIK 0001487428
$3.94 −0.02 (−0.51%)
Oct 26 4:00 PM ET · prev $3.96
Market cap
$268.1M
Micro cap
Consensus
Buy
58% Buy or better · 12 analysts
Median target
$5.00
+27% · range $4.50–6.00
Next earnings
Nov 5
in 10 days · EPS est. $0.18
1 year
−35.1%
from $6.07 · Oct 27
30 days
−13.2%
from $4.54
52-week range
$3.87–6.81
−42% from high · low Apr 27
Avg volume 20D
453.5K
Oct 15 spike 1.18M
Short interest
🔒 Subscribers only
Insider net
+$629.6K
6 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 3 reports · latest
Balance 0 bearish · 2 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/3 ·Next Earnings date, Nov 5, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    6 insiders bought $629.6K at an average $4.34. No open-market sales. Price is 9% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 9 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    7 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate $0.173 → $0.178 over 90 days. 1 up, 2 down in 30 days.

  • TrendDOWNTREND

    15% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYDOUBLED1,055,591$5.0M
MARSHALL WACE, LLPDOUBLED592,247$2.8M
BANK OF AMERICA CORP /DE/DOUBLED225,732$1.1M
UBS Group AGADD195,466$924.6K
LPL Financial LLCDOUBLED81,942$387.6K
OSAIC HOLDINGS, INC.ADD50,626$239.5K
ROYAL BANK OF CANADADOUBLED47,242$223.0K
IMC-Chicago, LLCTRIM40,074$189.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 58% rate it Buy or better
Strong Buy3Buy4Hold5Sell0Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +27%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Sep 1, 2026UBS
MAINTAIN
MAINTAINNeutral
Aug 21, 2026Keefe, Bruyette & Woods
MAINTAIN
MAINTAINMarket Perform
Aug 7, 2026Oppenheimer
MAINTAIN
MAINTAINPerform
May 18, 2026UBS
MAINTAIN
MAINTAINNeutral

Insider ledger

Form 4
$629.6K
bought · 6 insiders
$0
sold · 0 insiders
−9.3%
vs their $4.34 cost
DateInsiderTypeValue
Jun 10, 2026
Trolio Daniel R.
Executive VP and CFO
BUY$49.9K
Jun 9, 2026
O'Connor Kimberley Ann
Director
BUY$43.7K
Jun 9, 2026
Balkin Michael
Chief Executive Officer
BUY$434.0K
Jun 9, 2026
Seitz Paul G
Chief Investment Officer
BUY$49.9K
Jun 9, 2026
Goodman Jonathan Joseph
Director
BUY$25.9K
Jun 9, 2026
ALLISON THOMAS J.
Director
BUY$26.2K
Apr 14, 2026
Balkin Michael
Chief Executive Officer
AWARD93,527 sh
Apr 14, 2026
Seitz Paul G
Chief Investment Officer
AWARD142 sh

Earnings setup

Estimates
Nov 5
reports in 10 days
$0.18
EPS estimate, this quarter
+3%
estimate change, 90 days
1↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.18$0.17–$0.19-0.2%$25.1M
Next Q$0.17$0.16–$0.19+0.4%$26.1M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 4, 2026 Earnings calendar
HRZN Q2 2026 Earnings Scheduled — 2026-08-04
Jun 30, 2026 Inst.
MORGAN STANLEY — DOUBLED
1,055,591 shares ($5.0M)
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — DOUBLED
592,247 shares ($2.8M)
Jun 29, 2026 Event
Krystexxa
WARNING: ANAPHYLAXIS and INFUSION REACTIONS, G6PD DEFICIENCY ASSOCIATED HEMOLYSIS and METHEMOGLOBINE
Jun 11, 2026 SEC
Five HRZN insiders, including the CEO and CFO, made open-market purchases totaling ~$630K on June 9-10, 2026, at…
CLUSTER — Impact 5/10
Jun 10, 2026 SEC
Three insiders — CEO Michael Balkin, CIO Paul Seitz, and a director — collectively purchased ~$510K in HRZN shares at…
CLUSTER — Impact 5/10
Jun 10, 2026 Insider
Trolio Daniel R. bought 11,500 shares
Executive VP and CFO @ $4.34 ($49.9K)
Jun 9, 2026 Insider
O'Connor Kimberley Ann bought 10,000 shares
Director @ $4.37 ($43.7K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 4, 2026
Earnings date
HRZN Q2 2026 Earnings Scheduled — 2026-08-04
Jun 29, 2026
FDA
Krystexxa
WARNING: ANAPHYLAXIS and INFUSION REACTIONS, G6PD DEFICIENCY ASSOCIATED HEMOLYSIS and METHEMOGLOBINEMIA Anaphylaxis and infusion reactions have been r
May 5, 2026
Earnings date
HRZN Q1 2026 Earnings Scheduled — 2026-05-05
Mar 16, 2026
Short interest
FTD: HRZN — 280,249 shares ($1.1M) failed to deliver
Settlement: 20260316, Price: $4.10, FTD Value: $1,149,020.9, HORIZON TECHNOLOGY FINANCE COR
Mar 13, 2026
Short interest
FTD: HRZN — 157,402 shares ($0.7M) failed to deliver
Settlement: 20260313, Price: $4.32, FTD Value: $679,976.64, HORIZON TECHNOLOGY FINANCE COR

SecBot reports

3 filings · 2 bullish · 0 bearish · 1 mixed
All HRZN filing & press-release reports (3)